Furthermore, using a syngeneic mouse model of breast cancer dormancy, both orthotopic and metastatic, we confirmed the deleterious effects of taxane-based chemotherapy in dormancy awakening in vivo, and systemic release of proinflammatory cytokines IL-6 and G-CSF. The gene discussed is IL6; the disease is breast cancer.